Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2005
06/09/2005WO2005052191A2 Compositions and methods for the diagnosis and treatment of tumor
06/09/2005WO2005052174A2 Lactic acid producing yeast
06/09/2005WO2005052172A1 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv)
06/09/2005WO2005052171A2 Retroviral and lentiviral vectors
06/09/2005WO2005052170A2 Gene silencing by using micro-rna molecules
06/09/2005WO2005052169A2 Plant disease resistance and sar regulator protein
06/09/2005WO2005052168A2 System for the inducible expression of recombinant proteins in cyanobacteria
06/09/2005WO2005052167A2 Plasmid maintenance
06/09/2005WO2005052166A1 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases.
06/09/2005WO2005052165A1 Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus
06/09/2005WO2005052164A1 Gene therapy
06/09/2005WO2005052162A1 Fatty acid elongase (fae) genes and their utility in increasing erucic acid and other very long-chain fatty acid proportions in seed oil.
06/09/2005WO2005052159A1 Latent phase viral interleukin-10-(vii-10) and uses thereof
06/09/2005WO2005052157A1 Il-23 and its receptor; related reagents and methods
06/09/2005WO2005052151A1 Improved protein expression systems
06/09/2005WO2005052148A2 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates
06/09/2005WO2005052145A2 Recombinant alkaliizing bacteria
06/09/2005WO2005052143A2 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
06/09/2005WO2005052133A2 Method and markers for determining the genotype of horned/polled cattle
06/09/2005WO2005052123A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
06/09/2005WO2005052121A2 Multivalent aptamers
06/09/2005WO2005051993A1 Novel muscle growth regulator
06/09/2005WO2005051983A2 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides
06/09/2005WO2005051977A2 Conditional allele system
06/09/2005WO2005051971A1 Reduction of dermal scarring
06/09/2005WO2005051970A2 Highly parallel dna synthesiser based on matrices
06/09/2005WO2005051433A1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent
06/09/2005WO2005051432A1 Therapeutic regimen for treating cancer
06/09/2005WO2005051431A1 Colloidal delivery system for biological therapeutic agents
06/09/2005WO2005051430A1 Novel use of adenoviruses and nucleic acids that code for said viruses
06/09/2005WO2005051425A1 Procaspase 1 activation inhibitor
06/09/2005WO2005051423A2 Methods and agents for immune modulation and methods for identifying immune modulators
06/09/2005WO2005051421A2 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
06/09/2005WO2005051351A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
06/09/2005WO2005051291A2 B-cell-targeted toxin for immuno response reduction
06/09/2005WO2005051174A2 Nucleic acid aptamer-based compositions and methods
06/09/2005WO2005042774A3 Method for linking sequences of interest
06/09/2005WO2005040381A8 Rice and products thereof having starch with an increased proportion of amylose
06/09/2005WO2005035773A8 Modified cea /b7 vector
06/09/2005WO2005032473A3 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
06/09/2005WO2005030970A3 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances
06/09/2005WO2005030787A3 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
06/09/2005WO2005028658A3 Recombinant influenza vectors with a polii promoter and ribozymes
06/09/2005WO2005028623A3 Broad host range pbbr1-based plasmid mutant derivatives having altered plasmid copy number
06/09/2005WO2005026369A3 Interference rna expression vectors, methods for the production and use thereof
06/09/2005WO2005023854A3 Modified 6-phosphofructo-1-kinase of the fungus aspergillus niger
06/09/2005WO2005021765A3 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
06/09/2005WO2005017198A3 Surface display expression system
06/09/2005WO2005017153A3 Methods for synthesis of defined polynucleotides
06/09/2005WO2005014812A3 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia
06/09/2005WO2005014638A3 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family
06/09/2005WO2005014039A3 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases
06/09/2005WO2005013903A3 Derivatives of substituted quinone and uses thereof
06/09/2005WO2005012576A3 Molecular markers for the selection of soybean plants having superior agronomic performance
06/09/2005WO2005012537A3 Adenoviral vector-based vaccines
06/09/2005WO2005010142A3 Plant centromere compositions
06/09/2005WO2005007852A3 Room temperature elution of nucleic acids
06/09/2005WO2005001103A3 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
06/09/2005WO2005001034A3 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase
06/09/2005WO2004111267A3 Methods for preparation of a library of submegabase resolution tiling pools and uses thereof
06/09/2005WO2004111195A3 Methods and use of zona-free therapeutic cloning
06/09/2005WO2004110345A3 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
06/09/2005WO2004108756A3 Sars coronavirus peptides and uses thereof
06/09/2005WO2004106496A3 Methods and compositions for use in homologous recombination in plant cells
06/09/2005WO2004105737A3 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
06/09/2005WO2004104170A3 Tools for detecting moraxella catarrhalis.
06/09/2005WO2004094654A3 Transfection kinetics and structural promoters
06/09/2005WO2004084939A8 Hiv-peptide-carrier-conjugates
06/09/2005WO2004081177A3 Intracellular signaling pathways in diabetic subjects
06/09/2005WO2004081021A3 Oligonucleotide mimetics
06/09/2005WO2004076630A3 Covalent modification of rna for in vitro and in vivo delivery
06/09/2005WO2004072261A3 Sirna libraries optimized for predetermined protein families
06/09/2005WO2004065571A3 Dna molecules encoding a cotton chitinase and promoter
06/09/2005WO2004043383A8 A new target for angiogenesis and anti-angiogenesis therapy
06/09/2005WO2004039999A3 Essential dna enclosed proteins of drosphophilia melanogaster
06/09/2005WO2004035743A8 Site specific incorporation of keto amino acids into proteins
06/09/2005WO2004025264A3 Rapidly degraded reporter fusion proteins
06/09/2005WO2004000007A3 Methods of modulating cytokinin related processes in a plant using b3 domain proteins
06/09/2005WO2003097815A3 Molecular identification of aspergillus species
06/09/2005WO2003062400A9 Fiber shaft modifications for efficient targeting
06/09/2005WO2002038736A3 Methods for regulating plant gaba production
06/09/2005US20050125862 Materials and methods for producing tomato yellow leaf curl virus resistance in plants
06/09/2005US20050125861 DNA comprises the nucleotide sequences used for gene expression of foreign proteins in seeds; genetic engineering
06/09/2005US20050125860 Transgenic plants expressing CIVPS or intein modified proteins and related method
06/09/2005US20050125859 Modified galactosidase for use as tool in enzyme replacement therapy and treatment of lysosomal storage diseases in humans and animals
06/09/2005US20050125858 Oil biosynthesis
06/09/2005US20050125857 Using vector transformation to generate transgenic plants with enhanced replicase activity; improving crop yields; tissue engineering; improving exogenous gene expression
06/09/2005US20050125856 Serine O-acetyltransferase
06/09/2005US20050125855 Enhanced plant cell transformation by addition of host genes involved in T-DNA integration
06/09/2005US20050125854 Rice transposon genes
06/09/2005US20050125853 Preparing transgenic animal models via injection or aggregation of genetically modified foreign cells with wild type blastocysts or embryos; knock-out animals
06/09/2005US20050125852 Expression vector comprising nucleotide sequences coding protein and/or lipid kinases for use in generating animal models for prevention and treatment of pain, hypertensive, mood, inflammatory, skin, autoimmune, and psychological disorders
06/09/2005US20050125850 Generating marked chromosomes in mammalian somatic tissue via homologous recombination; tissue engineering and knockin mutants; animal models
06/09/2005US20050125849 Stem cell-specific promoters and their use
06/09/2005US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders
06/09/2005US20050125201 Data analyzer
06/09/2005US20050125160 Modifying the control of gene expression behavior by the deletion of connectrons and by the design and addition of synthetic connectrons in prokaryotic, archea and eukaryotic genomes
06/09/2005US20050124804 Reacting nucleoside with cyanoethyl-N,N,N',N'-tetraisopropyl-phosphorodiamidite in presence of trifluoroacetic acid-diisopropylethylamine complex
06/09/2005US20050124803 Genetically engineered insecticidal protein for use in controlling mosquito population; biological pest control
06/09/2005US20050124802 Novel human membrane proteins and polynucleotides encoding the same
1 ... 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 ... 4023